











Kulkarni, Vishwesh V. and Islam, Fazul (2016) Discrete-time L1 adaptive controller to 
regulate in vivo protein expressions. In: QSP-UK 1st Exchange Workshop 2016, University of 
Surrey, 5-7 Sep 2016. Published in: QSP-UK 1st Exchange Workshop 2016. 
 
Permanent WRAP URL: 
http://wrap.warwick.ac.uk/84217    
 
Copyright and reuse: 
The Warwick Research Archive Portal (WRAP) makes this work by researchers of the 
University of Warwick available open access under the following conditions.  Copyright © 
and all moral rights to the version of the paper presented here belong to the individual 
author(s) and/or other copyright owners.  To the extent reasonable and practicable the 
material made available in WRAP has been checked for eligibility before being made 
available. 
 
Copies of full items can be used for personal research or study, educational, or not-for-profit 
purposes without prior permission or charge.  Provided that the authors, title and full 
bibliographic details are credited, a hyperlink and/or URL is given for the original metadata 
page and the content is not changed in any way. 
 
A note on versions: 
The version presented here is a working paper or pre-print that may be later published 
elsewhere.  If a published version is known of, the above WRAP URL will contain details on 
finding it. 
 
For more information, please contact the WRAP Team at: wrap@warwick.ac.uk 
 
Discrete-Time L1 Adaptive Controller to Regulate In Vivo Protein Expressions 
 
Vishwesh Kulkarni and Fazul Islam 
School of Engineering, University of Warwick, Coventry CV4 7AL 
(V.Kulkarni @warwick.ac.uk and F.Islam@warwick.ac.uk) 
 
Abstract: The application of DNA nanotechnology to interface with cellular environment 
provides tremendous opportunities to expand the synthetic biological circuits. The current 
application of DNA nanotechnology spans smart therapeutics (Douglas et al, Science 2012), 
drug delivery (Perrault, Shih, ACS Nano 2014), imaging (Choi et al, ACS Nano 2014), and 
probes for cell biology (Shaw et al, Nat Methods 2014). The excellent programmability of 
nucleic-acid-based parts would enlarge the space of complex functionalities realized in 
synthetic biological circuits.  Building on our earlier works on DNA strand displacement 
circuits to regulate DNA tweezers driven by transcriptional oscillators, we show how discrete-
time L1 adaptive controller can be used to deliver drugs in situ in response to cellular 
condition. For this, we replace the model predictive controller used (Menolascina et al, PLOS 
CB 2014). Our controller automatically regulates the administration of inducer molecules to 
the cells by comparing the actual protein expression level in the cell population with the 
desired expression level. We intend to use in the automated platform of (Menolascina et al, 
PLOS CB 2014) which is based on a microfluidic device, a time-lapse microscopy apparatus, 
and a set of motorized syringes, all controlled by a computer. They have tested the platform 
to force yeast cells to express a desired fixed, or time-varying, amount of a reporter protein 
over thousands of minutes. Here, the computer automatically switched the type of sugar 
administered to the cells, its concentration and its duration, according to the control 
algorithm. Our discrete-time L1 adaptive controller facilitates superior results on controlling 
expression of any protein, fused to a fluorescent reporter, provided that an external molecule 
known to (indirectly) affect its promoter activity is available.  
 
Conceptually, our controller is also compatible to work with optogenetic systems that allow 
one to generate desired perturbations in the intracellular concentration of a specific protein in 
microbial cell culture. As light can be easily added and removed, this enables an easier 
dynamic control of protein concentration in culture than would be possible with long-lived 
chemical inducers. Implementation of this closed-loop control scheme is achieved by 
sampling individual cells from the culture apparatus, imaging and quantifying protein 
concentration, and adjusting the inducing light appropriately. The culturing apparatus can be 
operated as a chemostat, allowing one to precisely control microbial growth and providing 
cell material for downstream assays. Apart from the obvious applications in phenotype 
regulations, this method of specifically perturbing the concentration of a single protein and 
measuring the downstream signaling and transcriptional responses will allow 
experimentalists to make more informative perturbations to better elucidate the kinetics and 
architecture of biological networks for disease diagnosis and drug delivery. 
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